clinical trials in Turkey, Türkiye clinical trials, information about clinical trials in Türkiye, Türkiye CRO
Clinical Trials in Türkiye Firstly, it is official – Turkey is now Türkiye. This change took place past summer when the United Nations officially recognized the new name.  With a population of over 85 million, a well developed universal healthcare system, a relatively low per capita number of clinical trials, a large pool of treatment-naive patients, Türkiye is a
Cromos Pharma Expanding in Turkey, Kazakhstan and Serbia countries, clinical trials in Türkiye, clinical trials in Kazakhstan, Clinical trials in Serbia, cro in Türkiye, CRO in Kazakhstan & CRO in Serbia
Cromos Pharma Solidifies Its Operational Presence in Türkiye, Kazakhstan and Serbia Portland, OR, September 20, 2022 (EINPresswire) Cromos Pharma, a US-based international CRO with strong presence in Central and Eastern Europe today announced its ambitious expansion plans. The company is strengthening its presence in Turkiye, Kazakhstan and Serbia by establishing local legal entities, opening full scale offices, and increasing the local staff presence. The company plans
World Lymphoma Awareness Day, wlad, lymphoma clinical trials, lymphoma statistics
World Lymphoma Awareness Day 2022 World Lymphoma Awareness Day is recognized worldwide for educating people about cancer of the lymphatic system. Lymphoma is a cancer of the lymphatic system, lymphatic glands, and lymphocytes. There are two main types of lymphoma: Hodgkin’s and Non-Hodgkin’s. The former type is more prevalent in younger patients and the latter in the elderly population. Some

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM